Carmine Giorgio

1.4k total citations
49 papers, 919 citations indexed

About

Carmine Giorgio is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Analytical Chemistry. According to data from OpenAlex, Carmine Giorgio has authored 49 papers receiving a total of 919 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cellular and Molecular Neuroscience, 19 papers in Molecular Biology and 19 papers in Analytical Chemistry. Recurrent topics in Carmine Giorgio's work include Axon Guidance and Neuronal Signaling (32 papers), Chromatography in Natural Products (19 papers) and Apelin-related biomedical research (7 papers). Carmine Giorgio is often cited by papers focused on Axon Guidance and Neuronal Signaling (32 papers), Chromatography in Natural Products (19 papers) and Apelin-related biomedical research (7 papers). Carmine Giorgio collaborates with scholars based in Italy, United Kingdom and United States. Carmine Giorgio's co-authors include Massimiliano Tognolini, Alessio Lodola, Elisabetta Barocelli, Matteo Incerti, Ilaria Zanotti, Daniele Pala, Lisa Flammini, Vigilio Ballabeni, Marco Mor and Riccardo Castelli and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

Carmine Giorgio

47 papers receiving 907 citations

Peers

Countries citing papers authored by Carmine Giorgio

Since Specialization

Citations

This map shows the geographic impact of Carmine Giorgio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmine Giorgio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmine Giorgio more than expected).

Fields of papers citing papers by Carmine Giorgio

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmine Giorgio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmine Giorgio. The network helps show where Carmine Giorgio may publish in the future.

Co-authorship network of co-authors of Carmine Giorgio

This figure shows the co-authorship network connecting the top 25 collaborators of Carmine Giorgio. A scholar is included among the top collaborators of Carmine Giorgio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmine Giorgio. Carmine Giorgio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dual targeting of EphAs and KDR axis hampers VEGF-induced angiogenesis and glioma stem cell replication 2025 ·Biochemical Pharmacology ·(unknown), (unknown), Carmine Giorgio, (unknown), Ilaria Zanotti, Simona Parrinello, Melanie Clements, Marco Rusnati, (unknown), (unknown), (unknown), (unknown), Laura Scalvini, Alessio Lodola, Massimiliano Tognolini	0
2	Benzofuran‐2‐Carboxamide Derivatives as Immunomodulatory Agents Blocking the CCL20‐Induced Chemotaxis and Colon Cancer Growth 2024 ·ChemMedChem ·(unknown), (unknown), Carmine Giorgio, (unknown), (unknown), (unknown), Simona Bertoni, Marco Radi	0
3	Ephrin receptor type-A2 (EphA2) targeting in cancer: a patent review (2018–present) 2024 ·Expert Opinion on Therapeutic Patents ·Massimiliano Tognolini, (unknown), (unknown), Carmine Giorgio	2
4	A Pharmacological Investigation of Eph-Ephrin Antagonism in Prostate Cancer: UniPR1331 Efficacy Evidence 2023 ·Pharmaceuticals ·Claudio Festuccia, (unknown), (unknown), Riccardo Castelli, Alessio Lodola, Giovanni Luca Gravina, Massimiliano Tognolini, Carmine Giorgio	1
5	Molecular Determinants of EphA2 and EphB2 Antagonism Enable the Design of Ligands with Improved Selectivity 2023 ·Journal of Chemical Information and Modeling ·(unknown), (unknown), Laura Scalvini, (unknown), Carmine Giorgio, Riccardo Castelli, (unknown), Federica Vacondio, Silvia Rivara, Marco Mor, Chiara Urbinati, Marco Rusnati, Massimiliano Tognolini, Alessio Lodola	4
6	Drug discovery: In silico dry data can bypass biological wet data? 2023 ·British Journal of Pharmacology ·Massimiliano Tognolini, Alessio Lodola, Carmine Giorgio	4
7	Protein-Protein Interaction Inhibitors Targeting the Eph-Ephrin System with a Focus on Amino Acid Conjugates of Bile Acids 2022 ·Pharmaceuticals ·(unknown), Riccardo Castelli, Laura Scalvini, Francesca Ferlenghi, (unknown), Carmine Giorgio, Massimiliano Tognolini, Alessio Lodola	9
8	Discovery of small-molecules targeting the CCL20/CCR6 axis as first-in-class inhibitors for inflammatory bowel diseases 2022 ·European Journal of Medicinal Chemistry ·(unknown), Carmine Giorgio, (unknown), (unknown), Elisabetta Barocelli, Vigilio Ballabeni, Martyna Szpakowska, Andy Chevigné, Jan Piet van Hamburg, Nadine Davelaar, Erik Lubberts, Simona Bertoni, Marco Radi	15
9	Hypericin–Apomyoglobin: An Enhanced Photosensitizer Complex for the Treatment of Tumor Cells 2019 ·Biomacromolecules ·Paolo Bianchini, (unknown), Michele Oneto, Luca Pesce, Francesca Pennacchietti, Massimiliano Tognolini, Carmine Giorgio, Santi Nonell, Luigi Cavanna, Pietro Delcanale, Stefania Abbruzzetti, Alberto Diaspro, Cristiano Viappiani	24
10	Targeting the Eph/Ephrin System as Anti-Inflammatory Strategy in IBD 2019 ·Frontiers in Pharmacology ·Andrea Grandi, (unknown), (unknown), Carmine Giorgio, Massimiliano Tognolini, Francesco Marchesani, Stefano Bruno, Lisa Flammini, Anna Maria Cantoni, Riccardo Castelli, Alessio Lodola, (unknown), Elisabetta Barocelli, Simona Bertoni	18
11	Drug-gut microbiota metabolic interactions: the case of UniPR1331, selective antagonist of the Eph-ephrin system, in mice 2019 ·Journal of Pharmaceutical and Biomedical Analysis ·Francesca Ferlenghi, Riccardo Castelli, Laura Scalvini, Carmine Giorgio, (unknown), Massimiliano Tognolini, Marco Mor, Alessio Lodola, Federica Vacondio	9
12	Enhanced photosensitizing properties of protein bound curcumin 2019 ·Life Sciences ·(unknown), Pietro Delcanale, (unknown), Massimiliano Tognolini, Carmine Giorgio, (unknown), Luigi Cavanna, Paolo Bianchini, Alberto Diaspro, Stefania Abbruzzetti, Cristiano Viappiani	24
13	UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice 2018 ·Oncotarget ·Claudio Festuccia, Giovanni Luca Gravina, Carmine Giorgio, A. Mancini, Cristina Pellegrini, Alessandro Colapietro, Simona Delle Monache, Maria Giovanna Maturo, Roberta Sferra, Paola Chiodelli, Marco Rusnati, (unknown), Riccardo Castelli, Federica Vacondio, Alessio Lodola, Massimiliano Tognolini	28
14	Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction 2017 ·Biochemical Pharmacology ·Carmine Giorgio, Matteo Incerti, (unknown), Marco Rusnati, Paola Chiodelli, (unknown), Donatella Callegari, Francesca Ferlenghi, Vigilio Ballabeni, Elisabetta Barocelli, Alessio Lodola, Massimiliano Tognolini	21
15	Targeting Eph/ephrin system in cancer therapy 2017 ·European Journal of Medicinal Chemistry ·Alessio Lodola, Carmine Giorgio, Matteo Incerti, Ilaria Zanotti, Massimiliano Tognolini	66
16	Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 2015 ·Biochemical Pharmacology ·Carmine Giorgio, (unknown), Matteo Incerti, Antonella Bugatti, Federica Vacondio, Elisabetta Barocelli, Marco Mor, Daniele Pala, (unknown), Antimo Gioiello, Marco Rusnati, Alessio Lodola, Massimiliano Tognolini	10
17	Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Eph–ephrin system 2015 ·European Journal of Medicinal Chemistry ·Riccardo Castelli, Massimiliano Tognolini, Federica Vacondio, Matteo Incerti, Daniele Pala, Donatella Callegari, Simona Bertoni, Carmine Giorgio, (unknown), Ilaria Zanotti, Antonella Bugatti, Marco Rusnati, Claudio Festuccia, Silvia Rivara, Elisabetta Barocelli, Marco Mor, Alessio Lodola	38
18	1,8-Naphthyridines IX. Potent anti-inflammatory and/or analgesic activity of a new group of substituted 5-amino[1,2,4]triazolo[4,3-a][1,8]naphthyridine-6-carboxamides, of some their Mannich base derivatives and of one novel substituted 5-amino-10-oxo-10H-pyrimido[1,2-a][1,8]naphthyridine-6-carboxamide derivative 2014 ·European Journal of Medicinal Chemistry ·Mario Di Braccio, Giancarlo Grossi, Silvana Alfei, Vigilio Ballabeni, Massimiliano Tognolini, Lisa Flammini, Carmine Giorgio, Simona Bertoni, Elisabetta Barocelli	23
19	Lithocholic Acid Is an Eph-ephrin Ligand Interfering with Eph-kinase Activation 2011 ·PLoS ONE ·Carmine Giorgio, (unknown), Lisa Flammini, Elisabetta Barocelli, Matteo Incerti, Alessio Lodola, Massimiliano Tognolini	68
20	Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation 2011 ·Bioorganic & Medicinal Chemistry Letters ·Chiara Brullo, (unknown), Paola Fossa, Elena Cichero, Elisabetta Barocelli, Vigilio Ballabeni, Lisa Flammini, Carmine Giorgio, Francesca Saccani, (unknown), Olga Bruno	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact